Atezolizumab in patients (pts) with locally-advanced or metastatic urothelial carcinoma (mUC): Results from a pivotal multicenter phase II study (IMvigor 210)
Volume
51
Pagination
S720 - S720
DOI
10.1016/S0959-8049(16)31942-6
ISSN
0959-8049